The blockbuster Sanofi and Regeneron Pharmaceuticals drug Dupixent, already commercialized in several skin and lung disorders, has expanded its FDA-approval to chronic obstructive pulmonary ...

NEW YORK, Sept 23 (Reuters) - Sanofi's (SASY.PA), opens new tab chief executive, Paul Hudson, said in an interview on Monday that the company is poised for strong growth from a variety of new ...

NEW YORK (Reuters) -Sanofi's chief executive, Paul Hudson, said in an interview on Monday that the company is poised for strong growth from a variety of new drugs and is not facing imminent ...

Sanofi will present 39 abstracts across approved and pipeline ... Additionally, we are excited to share new data from our pipeline, including results for amlitelimab showing the potential to provide ...

NEW YORK (Reuters) -Sanofi's chief executive, Paul Hudson, said in an interview on Monday that the company is poised for strong growth from a variety of new drugs and is not facing imminent, costly ...

Sanofi ends speculation, confirms it will spend €1.3B to build new insulin plant in Germany More recently, Sanofi last month said it would shell out 1.3 billion euros ($1.4 billion) to build a ...

MC: There is no old or new model, but there is old school thinking and open school thinking. We are clearly conscious of this within Sanofi and we truly believe that we will overcome the future ...

Sept 16 (Reuters) - Sanofi (SASY.PA), opens new tab and partner AstraZeneca (AZN.L), opens new tab have received approval from the U.S. Food and Drug Administration for a manufacturing line for ...

This year’s ceremony spanned 15 awards, including a new honor for the agency of the year. The inaugural title went to Minds + Assembly, a New York City ... GSK’s vaccine. Sanofi’s North ...